Bank of Nova Scotia
ARRY

Bank of Nova Scotia’s Array Biopharma Inc ARRY Stock Holding History

Bank of Nova Scotia’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-122,600
Closed -$2M – 988
2018
Q1 		$2M Buy
+122,600
New +$1.96M 0.01% 568
2017
Q3 		– Sell
-133,300
Closed -$1.12M – 1019
2017
Q2 		$1.12M Sell
133,300
-366,700
-73% -$3M 0.01% 735
2017
Q1 		$4.47M Buy
+500,000
New +$5.32M 0.02% 429

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bank of Nova Scotia's ARRY Position: Q2 2018 in Review

Bank of Nova Scotia sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 122,600 shares — an estimated $2M sold.

Bank of Nova Scotia first reported a position in ARRY in Q1 2017 and held it in 3 quarters. The position peaked at $4.47M in Q1 2017. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Bank of Nova Scotia reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • Bank of Nova Scotia sold 122,600 Array Biopharma Inc shares in Q2 2018, an estimated $2M.
  • Bank of Nova Scotia first reported a position in Array Biopharma Inc in Q1 2017 and held it in 3 quarters.
  • Bank of Nova Scotia's Array Biopharma Inc position peaked at $4.47M in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Bank of Nova Scotia's 13F filing for Q2 2018, filed 14 Aug 2018.